11/1 ACE Biotek Partners with TWCA to Propel a New Era of Digital Medical Signatures and Information Security

Caption: ACE Biotek Chairman’s Assistant and Chief Information Security Officer, Mr. KC Chen

Hsinchu, Taiwan – November 1, 2023 – ACE Biotek and TAIWAN-CA (TWCA) proudly announce the signing of a MOU to address the critical concerns of information security in the healthcare sector. The development of smart hospitals often needs to improve information security and the establishment of legally binding document signatures. To meet these challenges, ACE Biotek has collaborated with TWCA to seamlessly integrate TWCA’s electronic signature and digital certificate technology into the existing ACE Biotek Uniiform digital handwriting system. This integration aims to provide a comprehensive solution that records digital signature trails and facilitates digital document storage.

As a pioneer of intelligent solutions in the healthcare industry, ACE Biotek has successfully led numerous departments toward digital transformation. Through products like Uniiform and DS, ACE Biotek has digitized handwritten medical records and enabled the capture and analysis of instrument data. TWCA, a globally recognized network authentication service provider, excels in information security and offers solutions such as digital signatures, certificates, and identity verification. Mr. KC Chen, Chairman’s Assistant, and Chief Information Security Officer of ACE Biotek, expressed his enthusiasm for this interdisciplinary collaboration, stating, “This partnership enhances the security and convenience of handwritten electronic forms and signatures in hospitals. Leveraging our strong backgrounds in information security and the medical field, ACE Biotek and TWCA have embarked on this cross-disciplinary endeavor.”

The collaboration between the two companies harnesses their respective strengths and aims to streamline the workflow of hospital IT departments. Moreover, it establishes mechanisms for legally binding documents. The primary focus of this cooperation is on Uniiform’s electronic signature solution and DS device identity verification. Uniiform, a core product of ACE Biotek, enables real-time digitalization of handwritten documents while retaining users’ handwriting habits and providing history records. By integrating TWCA’s information security solutions, the Uniiform electronic signature solution ensures practical legal effectiveness and traceable signature records, satisfying both online digital application and offline signing needs. The DS device identity verification solution aims to guarantee the identity of all hospital devices, enabling quick traceability of device operation history to enhance information security within the healthcare facility.

With the increasing focus on healthcare information security, the demand for legally effective electronic signatures continues to grow. The partnership between ACE Biotek and TWCA will pioneer new trends in healthcare information security. It will provide scientific and reliable solutions for hospitals to implement digital applications and signing mechanisms, ensuring the security of patient data and information. The future outlook includes expanding market applications to meet the needs of hospitals and government agencies. This collaboration is expected to drive Taiwan’s healthcare industry toward secure digital transformation and serve as a reference point for the global medical sector.

About ACE Biotek

Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, with a focus on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally, serving as a platform to foster talent and support tech companies in their transformation into Medtech.

Contact ACE Biotek

Advanced ACE Biotek Co., Ltd.

Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

ACE Biotek Joins the 2023 Kiss Science Event by the National Science and Technology Council

Figure1: ACE Biotek Kiss Science (National Hsinchu Industrial High School)
Figure2: ACE Biotek Kiss Science (Chiayi County Yung Ching Senior High School)

To inspire young minds to explore scientific research, the National Science and Technology Council has consistently hosted the “2023 Kiss Science – Unveiling Science, No More Dull Youth” event for the last five years. Commencing on October 14, 2023, and spanning five consecutive weekends, this initiative has opened doors to 106 venues across Taiwan, hosting more than 370 events. ACE Biotek, a pioneering name in Taiwan’s digital healthcare solution, has been invited to showcase its expertise by opening its corporate premises to students. On October 17, 2023, the company welcomed students from Hsinchu Industrial High School and Chiayi County Yung Ching Senior High School, offering them the opportunity to experience, interact, and engage in discussions to broaden their horizons and enhance their competitiveness.

ACE Biotek has made significant strides in promoting its electronic medical record and smart data integration solutions in various medical fields, including anesthesiology and ophthalmology. It has revolutionized the transition to electronic health records without altering healthcare professionals’ handwriting habits. The company extracts instrument data and processes it into a structured format. Early disease screening holds immense importance, necessitating state-of-the-art equipment for high-precision diagnosis. ACE Biotek combines multiple technological elements, including semiconductor chips, medical imaging algorithms, cloud technology, and artificial intelligence. Incorporating clinical expertise, regulatory certifications, and patented technology has led to the developing of advanced early disease screening systems.

The event commenced with guided tours through ACE Art Gallery, offering students insight into the fusion of technology and humanity within the corporate culture. Furthermore, students were given the opportunity to tour ACE Group’s transformation journey, transitioning from the 3C to Medical: Medical Talent, Medical Technology, and Medical Device. ACE Biotek also shared and delved into nurturing local medical talent and contributing to developing biotechnology, medicine testing, and medical equipment. The company presented a range of innovations, including the Uniiform Digital Handwriting System, AI integration into post-pandemic standard equipment, such as the O-Ring automatic hand dispenser, Wallie Screen thermal scanner, Einthoven ECG (Electrocardiogram) patches for remote healthcare, and THz (Terahertz) technology suitable for tablet or pathology slide applications. All these innovations were demonstrated through interactive experiences, informative lectures, and video presentations.

ACE Biotek has consistently emphasized talent development, believing in the correlation between the team’s growth and the company’s success. As a result, the company has been relentlessly working to provide the best nurturing and development environment, ensuring that every employee can fully realize their potential. The mission of ACE Biotek, evolving from 3C to Medical, underscores the company’s commitment to nurturing talents. Furthermore, ACE Biotek has extended its talent education into Corporate Social Responsibility (CSR), encouraging employees to participate in community service and charitable activities actively. This integration between personal growth and societal contribution is aimed at fostering a broader perspective within the team. From October 4 to December 29, 2023, the ACE Art Gallery will feature “Passing on Love DNA,” inviting the Evergreen Choir and Green Light Seed Classroom to convey love through songs and culture. All are welcome to attend.

About ACE Biotek

Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.

Contact us

Advanced ACE Biotek Co., Ltd.

Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

6/29 ACE Biotek and Proscend Successfully Hold 5G x Smart Health Cross-Border Seminar Showcasing Innovative IoT Applications and New Opportunities in Smart Healthcare Services

Caption: KC Chen, VP of ACE; Jason Lin, Director of TRANSNET; Alpha Chen, GM of PROSCEND; Jim Chen, Chairman of PROSCEND; Steve Hsu, President of ACE; Chanson Lin, President of EmBestor Technology; Kevin Kuo, ASD Supervisor of ACE; Eden Chao, Sr. Technical Manager of ACE; Nick Chiang, Hospital IT Professionals of ACE

ACE Biotek and Proscend successfully held the remarkable 5G x Smart Health Cross-Border Seminar on June 29, 2023, showcasing innovative IoT applications and new opportunities in smart healthcare services—the seminar aimed to demonstrate the outstanding collaborative achievements of the two companies. ACE Solution brings rich experience in wireless communication testing, AI technology, and medical data transmission, while Proscend excels in 5G, AIoT connectivity, smart internet services, and the development of high-value solutions, creating exemplary success stories for diverse vertical industries. The collaboration between the two companies has resulted in the development of comprehensive solutions that meet market demands.

The esteemed speakers for this event included Jason Lin, Director of TRANSNET, who delivered a fascinating analysis of empowering the intelligent 5G private network and creating a new digital transformation era by exploring key policies and international development trends and providing examples of their applications. Alpha Chen, GM of Proscend, shared insights into the industrial IoT smart applications of 5G x Edge AI computing, aiming to bring more innovative and high-quality service applications to meet the needs of smart healthcare. By forging alliances and co-creating an ecosystem of shared value, the goal is to advance together into new blue oceans, generate shared opportunities, and drive industry economic benefits. KC Chen, VP of ACE Biotek; Chanson Lin, President of EmBestor Technology; Nick Chiang, Hospital IT Professionals of ACE Biotek; Eden Chao, Sr. Technical Manager of ACE Solution; and Kevin Kuo, ASD Supervisor of ACE Biotek, discussed topics such as information security, hospital information system applications, 5G NR, WiFi 7, NB-IoT, and related issues.

The seminar also featured a showcase of several astonishing technological achievements, including 5G x Edge AI Intelligent Edge Computing Integration Solution, Smart Air Quality Management for Medical Facilities, O’smart IoT Smart Agile Management Service Platform, Intelligent Long-Distance Digital Network Communication Integration Solution, UniiForm Smart Handwriting Assistance System – Hand-drawn Electronic Medical Record Application, 5G testing solutions, Spark Smart Anesthesia Recording System, and DS Smart Upload Integration Solution. These demonstrations highlighted the strengths of both parties’ technologies and the innovative services with broad future applications.

This collaboration and seminar effectively leveraged the synergistic effects of both parties’ technologies to introduce more intelligent and advanced technological applications to the healthcare industry. ACE Biotek and Proscend will continue to deepen their cooperation, striving to promote the application of 5G and AIoT in smart healthcare, bringing more innovation and breakthroughs and further enhancing smart healthcare services.

About Proscend

Founded in 1999, Proscend is a leading provider of industrial IoT connectivity solutions, empowering the future of 5G and AIoT innovation. With a commitment to excellence and continuous improvement, Proscend stands at the forefront of creating unique and differentiated solutions, guiding us towards an infinite future. With an agile and customer-centric approach, Proscend serves over 60 countries globally as a trusted partner, delivering high-quality industrial-grade networking equipment and optimized IoT management platforms. By offering top-notch and robust solutions, Proscend enables efficient and intelligent transformations across multiple industries, including smart cities, smart transportation, smart energy, smart retail, and smart healthcare. Proscend is dedicated to fostering a symbiotic, prosperous, and sustainable world.

Contact Proscend

Proscend Communications Inc.

Address: 2F, No. 36, Industrial East 4th Rd., Hsinchu Science Park, Hsinchu City 300093, Taiwan

Phone: +886-3-5639000

E-mail: sales@proscend.com

Website: https://www.proscend.com/

About ACE Biotek

Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, with a focus on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally, serving as a platform to foster talent and support tech companies in their transformation into Medtech.

Contact ACE Biotek

Advanced ACE Biotek Co., Ltd.

Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

6/12 ACE Biotek and Proscend Sign Memorandum of Understanding – Collaborating to Create a New Era of 5G Smart Healthcare

Caption: Jim Chen, Chairman of Proscend; Steve Hsu, Chairman of ACE Biotek; Alpha Chen, General Manager of Proscend

Hsinchu, Taiwan – ACE Biotek and Proscend officially signed an MOU on June 12, 2023. Mr. Steve Hsu, Chairman of ACE Biotek, and Mr. Jim Chen, Chairman of Proscend, attended the signing ceremony. The collaboration aims to strengthen cooperation in 5G private networks, AIoT, AI, and DS gateways for smart internet and smart hospitals, to create mutual value.

Both companies will collaborate on integrating solutions for the application of 5G and AIoT in smart IoT and smart hospital environments. Proscend brings its expertise to 5G and Edge AI technologies, while ACE Biotek contributes its knowledge in AI, Uniiform, DS gateways, and other hardware and software applications. The companies will jointly develop comprehensive solutions that meet market demands through this partnership. ACE Biotek is committed to developing smart healthcare solutions encompassing wireless communication testing, AI technology, and medical data transmission. Proscend focuses on the research and design of 5G and AIoT vertical applications and smart internet services. This collaboration presents new opportunities for the advancement of 5G smart healthcare.

Mr. Steve Hsu, Chairman of ACE Biotek, expressed his enthusiasm, stating, “Emerging technologies such as 5G and AIoT have immense potential in the field of smart healthcare. We look forward to collaborating with Proscend to develop innovative solutions that facilitate telemedicine and integrate medical data, ultimately providing healthcare professionals greater convenience and delivering increased value to the healthcare industry.” Mr. Jim Chen, Chairman of Proscend, added, “We have established ourselves as pioneers in the digital application of 5G and AIoT in Taiwan and have expanded our reach to encompass diverse business opportunities. This partnership will leverage the strengths of both companies, driving the development of 5G smart healthcare and introducing intelligent and advanced technological applications to the medical industry.”

To further promote the achievements of this collaboration, ACE Biotek and Proscend will host the “5G x Smart Healthcare Cross-Border Seminar” on June 29th. The seminar will feature presentations by industry leaders and professionals in Proscend, ACE Biotek, Transnet, Embestor, and hospital information systems/platforms. Attendees will gain in-depth insights into the latest trends and applications of 5G, AIoT, and smart healthcare. Advanced registration is now open at the following website:

Online Registration: https://register.acesolution.com.tw/20230629_5GxSmartHealth_Seminar

About Proscend

Founded in 1999, Proscend is a leading provider of industrial IoT connectivity solutions, empowering the future of 5G and AIoT innovation. With a commitment to excellence and continuous improvement, Proscend stands at the forefront of creating unique and differentiated solutions, guiding us towards an infinite future. With an agile and customer-centric approach, Proscend serves over 60 countries globally as a trusted partner, delivering high-quality industrial-grade networking equipment and optimized IoT management platforms. By offering top-notch and robust solutions, Proscend enables efficient and intelligent transformations across multiple industries, including smart cities, smart transportation, smart energy, smart retail, and smart healthcare. Proscend is dedicated to fostering a symbiotic, prosperous, and sustainable world.

Contact Proscend

Proscend Communications Inc.

Address: 2F, No. 36, Industrial East 4th Rd., Hsinchu Science Park, Hsinchu City 300093, Taiwan

Phone: +886-3-5639000

E-mail: sales@proscend.com

Website: https://www.proscend.com/

About ACE Biotek

Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, focusing on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally as a platform to foster talent and support tech companies in transforming into Medtech.

Contact ACE Biotek

Advanced ACE Biotek Co., Ltd.

Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

6/9 Indonesia’s PT Norma and Taiwan’s ACE Biotek Collaborate to Develop Indonesian Hospital Market

Caption: Eva Hayati, Operational Director of PT Norma and Steve Hsu, President of ACE Biotek
From left to right: Arrahman Oktavianda, Engineer Manager of PT Norma, Rudi Antoni, President Director of RAFA Topaz Utama, Steve Hsu, President of ACE Biotek, and Eva Hayati, Operational Director of PT Norma

[Taipei, Taiwan / Jakarta, Indonesia – June 9, 2023] Advanced ACEBIOTEK CO., LTD. (ACE Biotek) and PT NORMA Diagnostika Indonesia (PT Norma) are delighted to announce the signing of a Memorandum of Understanding (MOU) on June 9, 2023. This collaboration aims to jointly develop and explore opportunities in the Indonesian hospital market. Representatives in the signing ceremony are Steve Hsu, President of ACE Biotek, and Eva Hayati, Operational Director of PT Norma. Notably, the contract signing uses the Uniiform smart pen, symbolizing the integration of innovative technology into the partnership.

PT Norma, a leading provider of information systems (HIS) for Indonesian hospitals, is partnering with ACE Biotek, a specialist in developing smart hospital technologies. The collaboration will focus on integrating ACE Biotek’s Uniiform Smart Handwriting System (UniiForm) software into PT Norma’s HIS system. This integration will enable the introduction of advanced healthcare solutions in Indonesian hospitals, streamlining medical staff efforts and enhancing the quality of care. Uniiform preserves user behavior and synchronously uploads handwriting records in real-time, facilitating a paperless environment and enabling AI-driven extensive data analysis and early disease diagnosis.

The partnership between ACE Biotek and PT Norma originated from a visit where PT Norma witnessed ACE Biotek’s technological achievements. Recognizing the market potential and aligning with the Southeast Asian EMR trend, PT Norma identified Uniiform as the cutting-edge product that complements its vision for the Indonesian healthcare sector. This MOU signifies a significant stride towards advancing healthcare technology in Indonesia. By combining expertise, the companies aim to contribute to meet patient care enhancement and smart hospital development.

Expressing his enthusiasm for the partnership, Mr. Steve Hsu, President of ACE Biotek, stated, “We are excited to collaborate with PT Norma to introduce our Uniiform Smart Handwriting System to Indonesian hospitals. The MOU represents a significant step towards enhancing healthcare technology in Indonesia and improving patient care.”

Ms. Eva Hayati, Operational Director of PT Norma, shared similar sentiments, remarking, “We believe that the Uniiform Smart Handwriting System has immense potential in the Indonesian market. By integrating Uniiform into our HIS system, we aim to offer an advanced system that aligns with the EMR trends. We will expand the user reference site to multiple hospitals across Indonesia.”

For media inquiries, please contact:

Advanced ACE Biotek Co., Ltd.:

Jenny Lin

Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)

Phone: +886-3-5500909#3407

E-mail: jenny_lin@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

PT NORMA Diagnostika Indonesia:

Arrahman Oktavianda

Address: Jl. KRT Radjiman Widyodiningrat No A23 Cakung, Jakarta Timur, 13930

Phone: +6282317171799

E-mail: oktavianda@normaindonesia.co.id

Website: https://www.normaindonesia.co.id/

About ACE Biotek

Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.

About PT Norma

Established in 2014, PT. Norma has grown for almost than 10 years in the In Vitro Diagnostics and IT Healthcare Solution business across Indonesia. From its first foundation, PT. Norma Diagnostika Indonesia is focused on distribution of In Vitro Diagnostics medical devices and its consumables as well. In 2017, PT. Norma Diagnostika Indonesia start cooperation with Hospital Information System provider based in South Korea, and nowadays PT. Norma focusing on distributing IT Healthcare Solution with additional cooperation with PACS from South Korea and Laboratory Information Management System from India. In long term, PT. Norma will expand its business to become One-stop Solution for IT Healthcare in Indonesia.

5/30 ACE Biotek and TWCA (TAIWAN-CA Inc.) Sign Memorandum of Understanding to expand collaboration on Uniipen Smart Pen Technology and Electronic Signature Applications

Caption: Steve Hsu, President of ACE Biotek (left), and Stephen Lee, Chairman of TWCA (right), representing the signing of the ceremony.

ACE Biotek, known for its successful implementation of smart hospital solutions, officially signed a cooperation memorandum with TWCA on May 30, 2023. The collaboration aims to enhance the partnership between Uniipen smart pen technology and electronic signature applications, working together to create mutual value. Stephen Lee, Chairman of TWCA, and Steve Hsu, President of ACE Biotek, represented the signing ceremony.

TWCA is a leading global provider of network certification services dedicated to driving digital transformation and providing secure and reliable authentication solutions. Its innovative technology and excellent service quality have earned complete customer trust. As the pioneer from 3C to the medical industry, ACE Biotek combines its expertise in wireless communication hardware and software integration with AI platform technology to develop smart medical data upload solutions. These solutions are applied to electronic medical record digitization and instrument data acquisition and analysis, with successful collaborations and implementations in representative domestic hospitals. The signing of this MOU aims to combine the technical strengths of both parties by integrating electronic signature or encryption technology into smart handwriting applications.

Steve Hsu, President of ACE Biotek, stated that the signing of this cooperation memorandum represents an innovative strategy. In addition to being used for EMR, Uniiform smart handwriting system is also utilized with the Data Stream Gateway (DS), which retrieves and integrates device data. By combining it with TWCA’s electronic signature technology in the future, the applications can be expanded from healthcare to other industries. Integration with companies in the science park makes it possible to introduce the technology into more underserved areas.

Stephen Lee, Chairman of TWCA, also emphasized that this collaboration will focus on the innovative integration of electronic signatures with Uniipen smart pens. It represents the perfect combination of both companies’ core competencies and business focus. Through cooperation with ACE Biotek, the goal is to provide customers with a superior, convenient, and secure experience in handwritten electronic forms. The success of this collaboration is expected to bring continued growth and mutual value to both parties.

5/17 Collaboration Insights of TZ6000 from TeraView– The Nondestructive Wafer Testing Accomplishment in Semiconductor Industry

From left to right: TZ6000 System with TeraPulse Lx; Dr. Don Arnone, CEO of TeraView and Steve Hsu, President of ACE Solution

Dr. Don Arnone is the CEO of TeraView. In March 2023, he visited ACE Solution (ACE), the Taiwan representative partner that launched the TZ6000, a non-destructive wafer quality measurement tool. It incorporates with TeraView’s TeraPulse Lx technologies, particularly for crucial applications such as wafer and substrate defect inspection. TZ6000 characterizes the wafer properties by thickness, refractive index, resistivity, dielectric constant, and surface/subsurface defects scanning graph.

Key Driving Factors for TZ6000 Success and Market Advantages

To explore the market for TZ6000, Dr. Don Arnone shares two influencing factors: ” One is to transmit product information; the other is to make a demonstration to customer in terms of favorable impression.” Since 2023, the proof of concept (POC), the initial sales, will rely on sturdy teamwork. Based on ACE and TeraView professionals, TZ6000 is the thriving base for forward-looking. TeraView possesses competitive advantages of Terahertz instrument experience, while ACE has tremendous expertise for integration solutions such as TZ6000. Under the two leading companies’ cross-border cooperation, it will bring an unprecedented solution for customers.

Subsurface Damage (SSD) of semiconductor wafers commonly happens in the surface machining process. At present, wafer inspection relies on VIS/IR/UV optical inspection that can analyze the surface properties of the wafer but not the SSD because of its low penetration depth. Terahertz (THz) waves have the features of high penetration depth in semiconductor wafers for silicon, silicon carbide, and gallium nitride. Therefore, THz-based TZ6000 can meet the market needs for compound semiconductor wafer non-destructive inspection.

TZ6000 Accomplishment Insights from ACE and TeraView

From Dr. Don Arnone’s viewpoint, there are three takeaways for TZ6000 task achievement. ACE works enthusiastically and hard to reach our milestones and follows customer requirements. In addition, team flexibility brings the capability to address the challenge of market adoption. These factors are also key to take the TZ6000 from the project phase through to final commercialization. TeraView’s TeraPulse Lx System is the pioneer product for terahertz analysis. Specifically, it meets material inspection in imaging or spectroscopy applications for the compound semiconductor industry. The modular architecture and patented laser-gated photoconductive emitters and detectors are flexible and expandable. The system also boasts an industry-leading 3,200 ps time-delay line as standard. With a lightweight, compact core unit that allows easy transport, the TeraPulse Lx System incorporates the TeraPulse Lx modules to meet market demands.

Steve Hsu, President of ACE, says it’s a precious chance to collaborate with TeraView. ACE takes the lead in electrical precision tests, integrating service and solution. Through the TeraPulase Lx module and TZ6000 system incorporation, it frames a unique THz-TDS probe for simultaneous measurement of multiple parameters of wafer characterization. In the wafer manufacturing and R&D process, TZ6000 possesses user-friendly and graphically illustrated software for quality inspection. “TeraView and ACE have very complimentary skills and experience. Our partnership is a representative case of international cooperation. I’m proud of this unique accomplishment and enjoying working with President Steve’s team.”, Dr. Don Arnone says with trust. Starting the TZ6000 business in Taiwan, ACE has confidence in creating a great business via technology integration in the long run.

2023 Smart City Summit & Expo-Smart Healthcare Theme Pavilion: ACE Biotek Shares Digital Healthcare Integration System Achievement

ACE Biotek sales manager, Michael Wu and technical manager, Richard Lee

To build a “Sustainable Medicare x Infinite Hope” service in south Taiwan, Kaohsiung holds the “Smart City Summit & Expo” from March 30th to April 1st. The nine major medical institutions jointly exhibit innovative medical care to build a “Sustainable Medicare x Infinite Hope” medical service.

Consolidate medical institutions to Display Medicare Application Characteristics.

Most medical institutions in southern Taiwan are small and medium size based. In recent years, the south medical community has actively promoted the local industry and service quality. This exhibition brings together hospitals to participate in building industry clusters. ACE Biotek develops uploading systems for smart hospitals. This time, the company exhibits Uniiform digital handwriting system, Spark anesthesia recording system, and Eagle Park 100 ophthalmology uploading system. Through the live demo and case studies for the visitors, it inherits digital medical application knowledge to the public. The solution digitizes hand-drawn medical records without changing the user’s handwriting habits. It equips with Data Stream (DS) gateway to connect multiple medical devices to retrieve and save the data in a structured module. Many anesthesiology, ophthalmology, and dentistry department have implemented the plan.

Dual-purpose of Digitization and Carbon-Free to Promote ESG goal

ACE Biotek’s smart medical solution can achieve electronic and paperless, which aligns with this exhibition’s theme to reflect the digital and net-zero effectiveness for southern Taiwan. Meanwhile, it presents the ESG (environment, society, and governance) concept. The digital medical record can simplify the consultation process, achieve paperless, receive data automatically, and improve medical quality to reach sustainable operation. With the InfinityAI platform, sites like the Department of Anesthesiology of the Kaohsiung Armed Forces General Hospital have used ACE Biotek’s integration solution and the Wallie Screen thermal scanner. In addition, the VOTEM patient monitor is for real-time data transmission, specifically for military medical and ambulance areas. AI’s medical data analysis and telemedicine are also the core technology based.

Kaohsiung is one of the critical hubs of Southern Policy. The event specially invites government officials and other hospital directors overseas. After visiting the booth, they positively recognize ACE Biotek as a potential partner for the global market. During the pandemic, ACE biotek expanded the business to the United States, Japan, and Vietnam and will seize the EMR trend to market smart hospital products to southern Asia.

2/24 2023 Forum of Increase Health Investment and Strengthen National Competitiveness-Taipei Declaration on Heath Care Applies ACE Biotek Uniiform Handwriting System

Figure: 2023 Taipei Declaration on Heath Care: ACE Biotek Michael Wu, Sales Manager (The third from the right); Richard Lee, Technical Engineering Manager (The second from the right)
Figure: 2023 Taipei Declaration on Heath Care: Applies ACE Biotek Uniiform
Figure: 2023 Taipei Declaration on Heath Care: Applies ACE Biotek Uniiform
Figure: 2023 Taipei Declaration on Heath Care: ACE Biotek Michael Wu, Sales Manager

The recent international analysis report indicates that health medicare can enhance economic competitiveness, productivity, tax income, and biomedical innovation for society. In a post-pandemic era, investment in Health is the global trend. On 24th February, the Taiwan College of Healthcare Executives (TCHE) acts as a crowd-puller for the medical and pharmaceutical-related associations to hold a “Forum to Increase Health Investment and Strengthen National Competitiveness” together. Dr. Hung, Tzu-Jen, the associate dean of Shin Kong Wu Ho-Su Memorial Hospital and Chairman of TCHE, hosts the 2023 Taipei Declaration on Heath Care ceremony. ACE Biotek receives a special invitation to provide Uniiform digital handwriting system for singing.

MOU Partnerships – Join Interdisciplinary Forum

In 2022, Shin Kong Hospital built MOU Relationship with ACE Biotek to initiate AI-intelligent healthcare integration cooperation. Steve Hsu, President of ACE Biotek, announces, “it’s our honor to join the event with Shin Kong Hospital together. We are devoted to smart hospital system integration and data uploading. We will contribute to sustainable healthcare with everyone based on our technology.” The ceremony applies Uniiform, which many hospitals have already implemented. It can preserve user behavior and digitize handwriting directly. In addition, it’s available for many industrial applications, especially contract signing, financing, agriculture and animal husbandry, manufacturing, and experiment records. The declaration ceremony is a historic moment to witness many representatives use Uniiform for signature today. The forum focuses on strengthening health investment. Under industry, government, and academic cooperation overseas, Shin Kong Hospital, ACE Biotek, and TCHE look forward to accelerating Taiwan hospitals to pioneer the ” Health is an investment, not a cost” philosophy.

Bring the Health investment in Line with Global Standard-Strengthen national competitiveness.

Dr. Hung, Tzu-Jen, the Chairman of TCHE, welcomes special guests from the Japanese Chamber of Commerce & Industry Taipei (JCCI) and The European Chamber of Commerce Taiwan (ECCT) to promote Taiwan’s Health and smart medical investment worldwide. The speakers share the challenges from theory to practice. Gaining such experience can boost national competitiveness. Nowadays, Shin Kong Hospital has a Smart Healthcare Promotion Committee, the leader in the field and expert in information security management. ACE Biotek creates AI artificial intelligence modeling applications to improve the quality of medicare and patient care and give it back to society. Today’s declaration calls for the government to increase healthcare from 6.2% to over 8% of GDP by 2028. Such an increase can bring the level of health investment in line with international standards, strengthening national competitiveness and accelerating Taiwan to becoming a global leader in healthcare, biomedical innovation, and economic growth. The ceremony increases the prestige and performance of Taiwan’s health sustainability and digital healthcare. Based on MOU with Shin Kong Hospital, ACE Biotek will seize the EMR trend to apply Uniiform, AI, and Terahertz (THz) technology to e-health quality.

About ACE Biotek

Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.

Contact

Advanced ACE Biotek Co., Ltd.

Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)

Phone: +886 3 5500909

E-mail: service@acebiotek.com; jenny_lin@acebiotek.com

WebSite: https://www.acebiotek.com/en/

Linkedln: https://tw.linkedin.com/company/筑波科技股份有限公司?original_referer=https%3A%2F%2Fwww.google.com.tw%2F

Facebook: https://www.facebook.com/Acebiotek/

TZ6000 – a nondestructive wafer quality measurement tool for the compound semiconductor industry

Left: TZ6000 System incorporated with TeraPulse Lx; Middle: Steve Hsu, CEO of ACE Solution and Right: Dr. Philip Taday, Head of Application of TeraView

Hsinchu, Taiwan – ACE Solution, the leader and the provider in customized test solutions to meet customer needs in electrical components, devices and system manufactures, is pleased to announce the product launch of the TZ6000 – a nondestructive wafer quality measurement tool for the compound semiconductor industry. Incorporated with TeraView’s TeraPulse Lx technologies, the TZ6000 achieves nondestructive wafer quality measurements of thickness, refractive index, resistivity, dielectric constant, surface/subsurface defects at selected positions and whole wafer scanning map.    

Dr. JC Chen, VP of R&D of ACE Solution, commented “The quality of the semiconductor wafer determines the maximum achievable conversion efficiency to the final device.  Subsurface damages (SSD) of semiconductor wafers are easily induced during surface machining process includes rough grinding, fine grinding, and chemical mechanical polishing. Current wafer inspection systems which rely on VIS/IR/UV optical inspection can analysis the surface properties of the wafer but not the SSD, due to their low penetration depth. Terahertz (THz) wave has higher penetration depth in semiconductor wafers as silicon, silicon carbide and gallium nitride. We developed the THz-based TZ6000 to meet the market need of nondestructive inspection of the compound semiconductor wafer.”

Dr. Philip F. Taday, Head of Applications and Principal Scientist of TeraView, commented “The TeraPulse Lx system is TeraView’s world-leading product family for terahertz analysis. It has been designed to meet the needs of the material inspection in imaging or spectroscopy applications, and is ideal for compound semiconductors. The system’s modular architecture and TeraView patented laser-gated photoconductive emitters and detectors gives the user both flexibility and expandability. The system also boasts an industry-leading 3,200 ps time-delay line, as standard.”

Steve Hsu, CEO of ACE Solution, commented “ACE Solution is the leading company in providing electrical precision test, integrating service and solution. It is great opportunity to collaborate with TeraView and incorporate the TeraPulse Lx module into TZ6000 system for nondestructive wafer quality inspection. TZ6000 has high flexibilities for various sizes and forms of wafers. It is provided with TeraView’s unique THz-TDS probe for simultaneous measurement of multiple parameters of wafer characterization. TZ 6000 has a user-friendly and graphic illustrate software for quality inspection in wafer manufacturing process and R&D.”

Dr. Don Arnone,CEO of TeraView, commented “This is another first from TeraView to have a close collaboration with ACE Solution to develop this product, and we are quite confident that this product will set a new standard in compound semiconductor wafer quality analysis and defect inspection. The TeraPulse Lx system is designed with a lightweight compact core unit which allows for easy transport between locations. Incorporated with TeraView’s TeraPulse Lx modules, we can address the growing needs of the compound semiconductor wafer industry with this product.”

About ACE Solution

Founded in 2000, ACE Solution (https://www.acesolution.com.tw/en/index/) is located in Hsinchu City, Taiwan with branch offices in Suzhou and Shenzhen in China. Our mission is to provide customized test solutions to meet customer needs in electrical components, devices and system manufactures, as well as providing technology solutions through our partners. We are focused on RF, mmWave and terahertz with the expert technical support team. ACE Solution provides professional, innovative and multi-functional integrated techniques and solutions.

About TeraView

Founded in 2001, TeraView (https://teraview.com/) is the world’s first and leading company solely focused on the application of terahertz light to provide solutions to customer issues. A spin out from the Toshiba Corporation and Cambridge University, TeraView has developed its proprietary technology across a number of markets. These include fault analysis and quality assurance for semiconductor chips used in mobile computing and communications, as well as non-destructive inspection of high value coatings used in the automotive, pharmaceutical, food and solar industries.

Contact

ACE Solution, Co., Ltd.

Address: 2F-1, No.28, Taiyuan street, Jhubei City, Hsinchu County, 302, Taiwan

Telephone: +886 3 5500909

E-mail: thzlab@acebiotek.com

WebSite: https://www.acesolution.com.tw/en/index/